Ascentage Pharma (002755.SZ): Marketing Authorization Application for Innovative Drug Omeprotafib Monoclonal Antibody Accepted

Zhitong Finance APP news, Aosaikang (002755.SZ) announced that its subsidiary Jiangsu Aosaikang Biopharmaceutical Co., Ltd. recently received the Notice of Acceptance issued by the National Medical Products Administration, and the domestic production drug registration and marketing authorization application for the company's innovative drug Ometotamab has been accepted.